The DOI matches its Crossref record; its reference list is not available.
Federal Policymakers Should Urgently and Greatly Expand Naloxone Access
Open accessAbstract
Federal Policymakers Should Urgently and Greatly Expand Naloxone Access Raagini JawaMD, MPH, Stephen MurrayBBA, Marco ToriMD, MSc, Jeffrey BratbergPharmD, and Alexander WalleyMD, MSc Affiliation Raagini Jawa is with the Grayken Center for Addiction and Clinical Addiction Research and Education Unit, Section of General Internal Medicine and the Section of Infectious Disease, Department of Medicine, Boston University School of Medicine, Boston, MA. Stephen Murray is with the Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine and a trainee at Boston University School of Public Health. Marco Tori is with the Division of General Internal Medicine, Boston University School of Medicine. Jeffrey Bratberg is with the College of Pharmacy, University of Rhode Island, Kingston. Alexander Walley is with the Grayken Center for Addiction and with Clinical Addiction Research and Education Unit, Boston University School of Medicine. CopyRightCorrespondence should be sent to Raagini Jawa, MD, MPH, Section of Infectious Disease and General Internal Medicine, School of Medicine, Boston University, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118 (e-mail: raagini.jawa@bmc.org). Reprints can be ordered at http://www.ajph.org by clicking the "Reprints" link. CONTRIBUTORS R. Jawa conceptualized and drafted the article. S. Murray, M. Tori, J. Bratberg, and A. Walley contributed to preparing and revising…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Our findings support previously published studies regarding the effectiveness of widespread naloxone distribution to people who use illicit drugs.
“Our findings support previously published studies regarding the effectiveness of widespread naloxone distribution to people who use illicit drugs [10, 15,51–54].”
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 7 · Cited by 10
Research works printed but not linked: 10
- 10.1016/j.drugpo.2021.103435 · DOI
- 10.1177/2042098614564776 · DOI
- 10.1056/NEJMsa1912403 · DOI
- Wheeler E, 2015, MMWR Morb Mortal Wkly Rep., 64, 631
- Doe-Simkins M, medRxiv.
- Murrin S., 2020, CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid.
- 10.15585/mmwr.mm6831e1 · DOI
- Department of Veterans Affairs, 2021, Fed. Regist., 86, 52072
- 10.2105/AJPH.2020.305620 · DOI
- 10.1001/jamanetworkopen.2019.6215 · DOI
Metadata
- Authors
- Jawa, R., Murray, S., Tori, M., Bratberg, J., & Walley, A.
- Affiliations
- Boston University (US)
- Venue
- American Journal of Public Health
- Publisher
- American Public Health Association
- Published
- 2022-04
- Volume
- 112
- Issue
- 4
- Pages
- 558-561
- ISSN
- 0090-0036 (ISSN-L)
- 1541-0048
- PMC
- PMC8961838
- OpenAlex
- W4220783570
- Cited by
- 10
- References
- 7
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Public Health (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K12DA050607, R25DA033211)
- National Institute of Allergy and Infectious Diseases (T32AI052074)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- naloxone, opioid overdose, opioid use disorder, federal policy, overdose prevention, naloxone access, harm reduction
- MeSH terms
- Humans, Naloxone, Narcotic Antagonists, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
